Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-12-31
2000-03-14
Lee, Howard C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 701, 514 25, 514183, 514187, 514297, 514451, 514453, 514457, 514880, A61K 3170, A61K 706
Patent
active
060373261
ABSTRACT:
Mammalian hair growth is reduced by applying to the skin an inhibitor of a DNA topoisomerase.
REFERENCES:
patent: 3426137 (1969-02-01), Philpitt et al.
patent: 4039669 (1977-08-01), Beyler et al.
patent: 4139638 (1979-02-01), Neri et al.
patent: 4161540 (1979-07-01), Neri et al.
patent: 4191775 (1980-03-01), Glea
patent: 4269831 (1981-05-01), Ferrari et al.
patent: 4370315 (1983-01-01), Greff et al.
patent: 4439432 (1984-03-01), Peat
patent: 4508714 (1985-04-01), Cecic et al.
patent: 4517175 (1985-05-01), Iwabuchi et al.
patent: 4720489 (1988-01-01), Shander
patent: 4885289 (1989-12-01), Brener et al.
patent: 4935231 (1990-06-01), Pigiet
patent: 5095007 (1992-03-01), Ahluwalia
patent: 5096911 (1992-03-01), Ahluwalia et al.
patent: 5132293 (1992-07-01), Shander et al.
patent: 5143925 (1992-09-01), Shander et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5271942 (1993-12-01), Heverhagen
patent: 5300284 (1994-04-01), Wiechers et al.
patent: 5364885 (1994-11-01), Ahluwalia et al.
patent: 5411991 (1995-05-01), Shander et al.
patent: 5455234 (1995-10-01), Ahluwalia et al.
patent: 5474763 (1995-12-01), Shander et al.
patent: 5554608 (1996-09-01), Ahluwalia et al.
Poot, "Impaired S-Phase Transit of Werner Syndrome Cells Expressed in Lymphoblastoid Cell Lines," Experimental Cell Research 202:267-273 (1992).
PCT International Search Report for PCT/US 97/24268, mailed May 26, 1998.
Pegg et al. Fundam. Appl. Toxicol., vol. 32(1): 45-52, (1996) (Abstract Only).
Berger et al., Nature, Structure and mechanism of DNA topoisomerase II, 225-32 1996.
Oh et al., Proc. Natl. Acad. Sci. USA, "An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation", 12525-30, 1996.
Benchokroun et al., Biochemical Pharmacology, "Aurintricarboxylic Acid, A Putative Inhibitor of Apoptosis is a Potent Inhibitor of DNA Topoisomerase II In Vitro and in Chinese Hamster Fibrosarcoma Cells", 305-13, 1995.
Constantinou et al., Journal of Natural Products, "Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships", 217-25, 1995.
Harmon et al., British Journal of Dermatology, "Hair Fibre Production by Human Hair Follicles in Whole-organ Culture," 415-423, 1994.
Harmon et al., SID Abstracts, "12-O-Tetradecanoylphorbol-12-Acetate Inhibits Human Hair Follicle Growth and Hair Fiber Production in Whole-organ Cultures," 102:533 1994.
Philpott et al., Journal of Dermatological Science, "Human Hair Growth in vitro: A Model for the Study of Hair Follicle Biology," 7:S55-S72, 1994.
Gorbsky, Cancer Research, Cell Cycle Progression and Chromosome Segregation in Mammalian Cells Cultured in the Presence of the Topoisomerase II Inhibitors ICRF-187 . . . , 1042-48, 1994.
Wang, Advances in Pharmacology, "DNA Topoisomerases as Targets of Therapeutics: An Overview", 1-19, 1994.
Mizumoto et al., Molecular Pharmacology, Programmed Cell Death (Apoptosis) of Mouse Fibroblasts is Induced by the Topoisomerase II Inhibitor Etposide, 890-95, 1994.
Barrows et al., Makaluvamines, marine natural products, are actve anti-cancer agents and DNA topo II inhibitors, 333-347, 1993.
Jindo et al., The Journal of Dermatology, "Organ Culture of Mouse Vibrissal Hair Follicles in Serum-free Medium," 20:756-762, 1993.
Messenger, The Society for Investigative Dermatology, "The Control of Hair Growth: An Overview," 1011:4S-9S, 1993.
Li et al., Proc. Natl. Acad. Sci. USA, "Hair Shaft Elongation, Follicle Growth, and Spontaneous Regression in Long-term, Gelatin Sponge-supported Histoculture of Human Scalp Skin," 89:8764-8768, 1992.
Li et al., In Vitro Cell. Dev. Biol., "Skin Histoculture Assay for Studying the Hair Cycle," 28A:695-698, 1992.
Yanabe et al., Cancer Research, Inhibition of Topoisomerase II by Antitumor Agents Bis(2,6-dioxopiperazine) Derivatives, 4903-08, 1991.
Salzer et al., Pharmacology Hear. Res. "Cochlear Damage and Increased Threshold in Alpha-difluoromethylornithine DFMO Treated Guinea Pigs," 451-2:101-112, 1990 Abstract.
Drake et al., Cancer Research, In Vitro and Intracellular Inhibition of Topoisomerase II by the Antitumor Agent Merbarone, 2578-83, 1989.
Adlakha et al., Cancer Research, Modulation of 4'-(9-Acridinylamino)methanesulfon-m-anisidide-induced, Topoisomerase II-mediated DNA Cleavage by Gossypol, 2052-48, 1989.
Drlica et al., American Chemical Society, "Inhibitors of DNA Topoisomerases", 2253-59, 1988.
Heck et al., Proc. Natl. Acad. Society, Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle, 1086-90, 1988.
Goos et al., Arch. Dermatol. Res., "An Improved Method for Evaluating Antiandrogens," 273:333-341, 1982.
Johnson et al., Biochemistry, "Inhibition of Hexokinase and Protein Kinase Activities of Tumor Cells by a Chloromethyl Ketone Derivative of Lactic Acid," 2122:2984-2989, 1982.
Marini et al., The Journal of Biological Chemistry, "Decantentation of Kinetoplast DNA by Topoisomerases", 4976-79, 1980.
Simpson et al., British Journal of Dermatology, "The Effect of Topically Applied Progesterone on Sebum Excretion Rate," 100:687-692, 1979.
Sato, Biology and Disease of the Hair, "The Hair Cycle and its Control Mechanism," 3-13, 1976.
Adachi et al., J. Soc. Cosmet. Chem., "Human Hair Follicles: Metabolism and Control Mechanisms," 21:901-924, 1970.
Ahluwalia Gurpreet S.
Styczynski Peter
LandOfFree
Reduction of hair growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduction of hair growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of hair growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-169231